biotech

The flotation window stays open, for now
The flotation window stays open, for now
EP Vantage
IPOs
biotech
flotation
Flag link:
‘As good a model as I’ve seen’: MIT biologist on new initiative to address gender inequities in biotech
‘As good a model as I’ve seen’: MIT biologist on new initiative to address gender inequities in biotech
Stat
MIT
women
biotech
gender diversity
Flag link:
Biotech’s important clinical data readouts
Biotech’s important clinical data readouts
EP Vantage
biotech
Scholar Rock
apitegromab
spinal muscular atrophy
Alnylam
vutrisiran
Dicerna
nedosiran
Primary Hyperoxaluria
FDA
Flag link:
Here's Why Clinical-Stage Biotechs Get Hit Harder During a Market Decline
Here's Why Clinical-Stage Biotechs Get Hit Harder During a Market Decline
Motley Fool
biotech
Flag link:
Former Biotech Director Charged with Obstruction of Justice Over Attempts to Acquire Neurotoxin Ricin
Former Biotech Director Charged with Obstruction of Justice Over Attempts to Acquire Neurotoxin Ricin
BioSpace
biotech
ricin
bioterrorism
G.E.N.9-Bio
Flag link:
Record funding flowed into cell, gene therapy companies last year
Record funding flowed into cell, gene therapy companies last year
BioPharma Dive
biotech
funding
gene therapy
cell therapy
Flag link:
Three Biotechs Obtain Millions in New Financing Rounds Announced Monday
Three Biotechs Obtain Millions in New Financing Rounds Announced Monday
BioSpace
biotech
funding
ElevateBio
Graphite Bio
Insitro
Flag link:
Biotech Stocks: What Will 2021 Look Like?
Biotech Stocks: What Will 2021 Look Like?
Motley Fool
biotech
biotech stocks
Flag link:
Latest MassBio report shows just how much biopharma's biggest sector boomed in 2020
Latest MassBio report shows just how much biopharma's biggest sector boomed in 2020
Endpoints
MassBio
Massachusetts
biotech
Flag link:
Former AveXis executives launch gene therapy startup with uncommon targets
Former AveXis executives launch gene therapy startup with uncommon targets
BioPharma Dive
biotech
startups
AveXis
Zolgensma
gene therapy
Jaguar Gene Therapy
Flag link:
The reckoning begins for biotech-focused SPACs
The reckoning begins for biotech-focused SPACs
EP Vantage
SPAC
biotech
funding
Flag link:
Advent raises $215M to nurture another troop of biotechs
Advent raises $215M to nurture another troop of biotechs
Fierce Biotech
Advent Life Sciences
life sciences
venture capital
funding
biotech
Flag link:
University of Oregon Campus Could Be Cornerstone of New Biotech Hotspot
University of Oregon Campus Could Be Cornerstone of New Biotech Hotspot
BioSpace
biotech
Oregon
University of Oregon
Flag link:
Disgraced biotech investor Woodford plans revival amid UK life science boom
Disgraced biotech investor Woodford plans revival amid UK life science boom
Pharmaforum
Neil Woodford
UK
biotech
Flag link:
Ireland is open: The biologics boom boosting the Irish economy
Ireland is open: The biologics boom boosting the Irish economy
Pharmaforum
Ireland
biologics
biotech
Flag link:
Biotech flotations offer venture funds an accelerating exit
Biotech flotations offer venture funds an accelerating exit
EP Vantage
biotech
IPOs
startups
M&A
Flag link:
Arch raises $1.9B to build another crop of breakthrough biotechs
Arch raises $1.9B to build another crop of breakthrough biotechs
Fierce Biotech
Arch Venture Partners
funding
biotech
Flag link:
J.P. Morgan: Will Biotech’s Virtual 2021 Launch Become the New Reality?
J.P. Morgan: Will Biotech’s Virtual 2021 Launch Become the New Reality?
BioSpace
virtual meetings
biotech
JPMHC 2021
Flag link:
3 Biotech Stocks That Jumped Last Week
3 Biotech Stocks That Jumped Last Week
Motley Fool
biotech
biotech stocks
Lexicon Pharmaceuticals
sotagliflozin
Nucana
Aldeyra Therapeutics
reproxalap
Flag link:
The biotech resurrection continues
The biotech resurrection continues
EP Vantage
biotech
Lexicon Pharmaceuticals
DBV Technologies
Pfizer
Trillium Therapeutics
Flag link:

Pages